Clinical Trials

• Identification of Biomarkers That Can Predict Progression from Latent Tuberculosis Infection to

  Study Location: India

  Eligibility: Adult, Pediatric, Household contacts

  Enrollment:

  Read More

• ACTIV-2/A5401: Adaptive Platform Treatment for Outpatients with COVID-19 (Adapt Out COVID)

  Study Location: BaltimoreIndia

  Eligibility: Adults

  Enrollment:

  Read More

• P2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs during Pregnancy and

  Study Location: BaltimoreIndia

  Eligibility: Preg/postpartum women. Infants

  Enrollment:

  Read More

• The Pharmacokinetics, Safety and Acceptability of New Child-Friendly Formulations of Clofazimine and

  Study Location: India

  Eligibility: Pediatrics

  Enrollment:

  Read More

• Impact of Tuberculosis Infection on HIV-1 Antibody Response (NWCS501)

  Study Location: BaltimoreIndia

  Eligibility: Adults, adolescents

  Enrollment:

  Read More

• A5300B/I2003B/PHOENIX, Protecting Households On Exposure to Newly Diagnosed Index

  Study Location: India

  Eligibility: Men and women age greater than or equal to 18 year

  Enrollment:

  Read More

• P2010: Phase III Study of the Virologic Efficacy and Safety of Dolutegravir-Containing versus

  Study Location: India

  Eligibility: HIV-1-infected pregnant women initiating antiretroviral therapy at 14-28 weeks gestation, and their infants

  Enrollment:

  Read More

• P2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety,

  Study Location: India

  Eligibility: HIV-infected and HIV-uninfected infants, children, and adolescents less than 18 years of age with confirmed or probable MDR-TB.

  Enrollment:

  Read More

• A5253: Sensitivity and Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in

  Study Location: India

  Eligibility: Ages Eligible for Study:  13 Years and older   (Child, Adult, Senior) Sexes Eligible for Study:  All Accepts...

  Enrollment:

  Read More

• A5207, Maintaining Options for Mothers Study (MOMS): A Phase II Randomized Comparison of Three

  Study Location: India

  Eligibility: Ages Eligible for Study:  13 Years and older   (Child, Adult, Senior) Sexes Eligible for Study:  Female...

  Enrollment:

  Read More
•  1 2 3 >  Last ›